Boston Scientific (BSX)

SG&A Expense Growth

1.24%

Quarterly · Period ending:

BSX logo

BSX SG&A Expense Growth

Latest reported1.24%
BSX Quarterly SG&A Growth (QoQ) (0.00% → 1.24%)
High-resolution chart · PNG

BSX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
1.2353%
-2.8899%
5.3418%
1.4569%
7.4515%
-0.9305%
3.201%
8.0221%
6.0117%
-1.0877%
11.0306%
-8.2718%
11.4403%
4.4712%
4.025%
-4.0343%
9.9057%
-8.0659%
8.1614%
-4.9063%
10.0098%
-0.779%
4.3699%
23.3083%
-18.4049%
-10.4396%
7.9051%
4.5455%
11.3924%
-8.1395%
8.9862%
-2.5814%
4.5775%
-3.4014%
10.665%
-1.8473%
2.6549%
-4.4686%
7.8125%
-1.4121%
8.7989%
-7.8507%
6.5844%
4.1429%
4.7904%
-11.2882%
1.6194%
-0.2692%
11.5616%
-8.011%
10.0304%
-0.4539%
4.7544%
-1.252%
3.3981%
-11.3343%
-1.4144%
8.2695%
-1.8045%
-4.1787%
7.2643%
-10.2635%
7.1322%
-2.6049%
1.7673%
-68.9813%
205.7263%
-1.105%
-26.4228%
36.0996%
-27.3367%
51.9084%
-0.9077%
-6.108%
-2.0862%
-10.4608%
2.033%
3.8259%
5.4242%
-1.2363%
38.6667%
12.1795%
5.4054%
-5.7325%
9.2807%
-16.3107%
2.1825%
34.4%
7.7586%
11.1821%
6.1017%
1.0274%
7.7491%
1.8797%
6.8273%
1.2195%
2.0747%
-12.0438%
18.1034%
0.8696%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.